Q2 2026 ICON PLC Earnings Call Transcript
Key Points
- Strong bookings performance with Q2 gross business wins of $3.7 billion, up 24% year-over-year and 13% sequentially, and a net book-to-bill ratio of 1.51 times.
- Direct fee net book-to-bill ratio of 1.2 times, indicating robust underlying demand for core services.
- Broad-based demand across customer groups, with eight of the top 10 customers by awards coming from mid-sized and biotech sectors.
- Improving pipeline quality with Phase 3 opportunities representing approximately 50% of total opportunity volume, up from 40% a year ago.
- Strategic investments in AI (e.g., Anthropic collaboration) and expansion in China, including lab capabilities, to strengthen competitive position and long-term growth.
- Elevated pass-through activity negatively impacted reported margins, with adjusted gross margin falling to 23.8% from 29.1% year-over-year.
- Adjusted EBITDA margin declined to 15.9% from 20.5% in the prior year quarter, pressured by business mix and higher pass-throughs.
- Large pharma RFP flow moderated in Q2, introducing some uncertainty in demand from this key segment.
- Higher proportion of ballpark proposals in biotech, which typically have lower conversion rates, may temper future bookings growth.
- SG&A expense benefited from non-recurring items (e.g., R&D tax credits) in Q2, which are not expected to repeat in the second half, potentially pressuring margins.
Good day and thank you for standing by. Welcome to the Icon PLC Q2 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question during the session, you will need to press star one and one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one and one again. Please be advised that today's conference is being recorded. I will now. I'd like to turn the conference over to your first speaker today, Kate Haven. Please go ahead.
Hello, and thank you for joining us today. I'm joined on the call by our CEO, Barry Bell and our CFO, Nigel Clergan. I would like to note that this call is webcast and that there are slides available to download on our website to accompany today's call.
Certain statements in today's call will be forward-looking statements.
These statements are based on management
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
